Schedule your personal consultation with Dr
GLP-1s not found to increase risk of ischemic optic neuropathy Several observational studies have suggested that GLP-1 treatment in people with diabetes may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause blindness
Side effects requiring immediate medical attention include: Severe, persistent abdominal pain which may indicate pancreatitis (seek urgent medical care) Signs of gallbladder problems such as pain in the upper right abdomen, which can be common Severe allergic reactions (seek emergency care) Changes in vision, particularly in patients with diabetes The SmPC notes that in non-clinical studies, semaglutide caused thyroid C-cell tumours in rodents
Little is currently known about how these peripheral aversion-related actions of opioids are processed
Research published in Arthritis Research & Therapy highlights the potential of certain peptides to reduce joint inflammation and slow disease progression
Lifestyle changes are essential to achieving and sustaining a healthy weight with or without medication
